UPC_APP_60996/2024

TRANSCUTANEOUS ANALYTE SENSOR SYSTEMS AND METHODS

Procedural & sub-applicationsOther ProceduralDusseldorf LDGeneric application—

Overview Decisions Documents Timeline

Parties

Claimants

Dexcom Inc.(Dexcom Group)

Reps: Markus Grosch (Quinn Emanuel Urquhart & Sullivan LLP)

Respondents

Abbott Laboratories(Abbott Group)
Abbott Diabetes Care Inc.(Abbott Group)
Abbott GmbH(Abbott Group)
Abbott Diagnostics GmbH(Abbott Group)
Abbott Laboratories GmbH(Abbott Group)
Abbott Logistics B.V.(Abbott Group)
Abbott France (S.A.S.)(Abbott Group)
Abbott s.r.l.(Abbott Group)
Abbott Gesellschaft m.b.H.(Abbott Group)
Abbott B.V.(Abbott Group)
Abbott (S.A./N.V.)(Abbott Group)
Abbott Scandinavia Aktiebolag(Abbott Group)
Abbott Oy(Abbott Group)

Reps: Dietrich Kamlah (Taylor Wessing Partnerschaftsgesellschaft mbB); Christian Lederer (Taylor Wessing Partnerschaftsgesellschaft mbB); Gisbert Hohagen (Taylor Wessing Partnerschaftsgesellschaft mbB)

Judges

ThomasPresiding judge, judge-rapporteur

Patents

EP 4 026 488

CPC codes: A61B5/6849, A61B2560/063, A61B5/14865, A61B5/688, A61B5/14532, A61B5/14546, A61B5/6848, A61B5/6832, A61B5/68335, A61B2562/222, A61B2562/227, A61B2560/045…

Sector: Pharmaceutical & Medical

Outcome

Procedural only

Filed: —

First decided: Nov 20, 2024

Language: —